US OptionsDetailed Quotes

THTX241018C7500

Watchlist

0.05
0.000.00%

15min DelayClose Sep 27 16:00 ET

0.00High0.00Low

Theratechnologies Stock Discussion

Jaguar8

May 23 16:02

$Theratechnologies (THTX.US)$
NEWS
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
Theratechnologies announced promising Phase 1 data for its investigational drug, sudocetaxel zendusortide, at the 2024 ASCO annual meeting.
The drug showed long-term disease stabilization in patients with solid tumors, lasting up to 45 weeks even after treatment ceased.
The study highlighted a uni...

Jaguar8

May 2 06:31

$Theratechnologies (THTX.US)$
NEWS
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
05/02/2024 - 04:30 AM
First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors
Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the...

Trytosaveabit

Mar 21 07:35

Update

$Theratechnologies (THTX.US)$ NASDAQ: THTX) announced moving to the next dose level in Part 3 of its Phase 1 clinical trial of sudocetaxel zendusortide in patients with advanced ovarian cancer.

Meltyy

Jan 30 03:28

PDUFA Update…

📌Last week’s PDUFAs:
$Heron Therapeutics (HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia (LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies (THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...

Trytosaveabit

Jan 24 06:05

Oops! Expected

$Theratechnologies (THTX.US)$ Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA
4 MINUTES AGO, 7:00 AM EST

Trytosaveabit

Jan 24 06:04

$Theratechnologies (THTX.US)$ No new SEC filings except for yesterday’s FDA needs to review more? Could the FDA have come to a answer overnight? could it be a buyout? maybe a partner? hehehe! i love speculating! hehehe

Trytosaveabit

Jan 24 05:57

T1 Halt for news????

$Theratechnologies (THTX.US)$ Eyes on hard for what it could be now?

Trytosaveabit

Jan 23 06:33

Grrrrrr! Update

$Theratechnologies (THTX.US)$ •FDA continues to review the file past the Prescription Drug User Fee Act goal date of January 22, 2024
MONTREAL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received correspondence from the U.S. Food and Drug Administration (FDA) regarding the Company's supplemental Biolo...

Trytosaveabit

Jan 22 13:37

Hmm? They gonna wait til AH? Grrr!

$Theratechnologies (THTX.US)$ So i just checked and its still listed for a answer today 1/22/24 on the approval of sBLA

Trytosaveabit

Jan 19 10:32

Just a reminder for you to watch for!

$Theratechnologies (THTX.US)$ This is on the FDA PDUFA calendar for Monday 1/22/24

No comment yet